Biocure Technology Inc. CURE.CN Stock
Biocure Technology Inc. Price Chart
Biocure Technology Inc. CURE.CN Financial and Trading Overview
| Biocure Technology Inc. stock price | 0.02 CAD |
| Previous Close | 0.04 CAD |
| Open | 0 CAD |
| Bid | 0.04 CAD x 0 |
| Ask | 0.04 CAD x 0 |
| Day's Range | 0 - 0 CAD |
| 52 Week Range | 0 - 0.1 CAD |
| Volume | 0 CAD |
| Avg. Volume | 5.49K CAD |
| Market Cap | 3.81M CAD |
| Beta (5Y Monthly) | 2.568542 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0.03 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CURE.CN Valuation Measures
| Enterprise Value | 3.61M CAD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Biocure Technology Inc. Stock Price History
| Beta (5Y Monthly) | 2.568542 |
| 52-Week Change | -22.22% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.1 CAD |
| 52 Week Low | 0 CAD |
| 50-Day Moving Average | 0.05 CAD |
| 200-Day Moving Average | 0.04 CAD |
CURE.CN Share Statistics
| Avg. Volume (3 month) | 5.49K CAD |
| Avg. Daily Volume (10-Days) | 0 CAD |
| Shares Outstanding | 108.92M |
| Float | 108.82M |
| Short Ratio | 0.04 |
| % Held by Insiders | 25.71% |
| % Held by Institutions | 0% |
| Shares Short | 53 |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -18.32% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -316251 CAD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 10.8K CAD |
| Total Cash Per Share (mrq) | 0 CAD |
| Total Debt (mrq) | 82.54K CAD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.02 |
| Book Value Per Share (mrq) | -0.018 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -688696 CAD |
| Levered Free Cash Flow (ttm) | 2.71M CAD |
Profile of Biocure Technology Inc.
| Country | Canada |
| State | BC |
| City | Vancouver |
| Address | 1055 West Hastings Street |
| ZIP | V6E 2E9 |
| Phone | 604-609-7146 |
| Website | https://www.biocuretech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Biocure Technology Inc., together with its subsidiary, engages in developing and commercializing biopharmaceutical technologies for use in recombinant and ranibizumab. The company is developing Interferons-ß for the treatment of multiple sclerosis; Ranibizumab, a monoclonal antibody fragment for the treatment of macular degeneration, as well as to treat a type of eye problem known as macular edema; and Filgrastim to treat neutropenia, a lack of white blood cells caused by cancer, bone marrow transplant, chemotherapy, or by other conditions. It also engages in the research and development of CAR T Cell therapy that identifies and destroys cancer cells; a foot and mouth disease vaccine; and hair growth products. Biocure Technology Inc. was founded in 2005 and is headquartered in Vancouver, Canada.
Q&A For Biocure Technology Inc. Stock
What is a current CURE.CN stock price?
Biocure Technology Inc. CURE.CN stock price today per share is 0.02 CAD.
How to purchase Biocure Technology Inc. stock?
You can buy CURE.CN shares on the Canadian Sec exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Biocure Technology Inc.?
The stock symbol or ticker of Biocure Technology Inc. is CURE.CN.
Which industry does the Biocure Technology Inc. company belong to?
The Biocure Technology Inc. industry is Biotechnology.
How many shares does Biocure Technology Inc. have in circulation?
The max supply of Biocure Technology Inc. shares is 94M.
What is Biocure Technology Inc. Price to Earnings Ratio (PE Ratio)?
Biocure Technology Inc. PE Ratio is 0.50000000 now.
What was Biocure Technology Inc. earnings per share over the trailing 12 months (TTM)?
Biocure Technology Inc. EPS is 0.03 CAD over the trailing 12 months.
Which sector does the Biocure Technology Inc. company belong to?
The Biocure Technology Inc. sector is Healthcare.